Answers are grounded in this paper and cite their sources.
) in breast tumors have been observed as well. miRNAs and lncRNAs are considered targets of therapeutic intervention in breast cancer, but further work is needed to bring the promise of regulating their activities to clinical use.
No takes yet. Share an insight, caveat, or question.
Carolyn M. Klinge (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: